SLCO1B3 and neoplasm: It is generally accepted that 85% of HCCs show hypointensity in the hepatobiliary phase of EOB-MRI compared to noncancerous liver, with a reduction of OATP1B3 protein or OATP1B3 gene expression in the tumour.